Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002
about
NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007The growing burden of antimicrobial resistance.Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission.Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issuesCitrobacter spp. simultaneously harboring blaCTX-M, blaTEM, blaSHV, blaampC, and insertion sequences IS26 and orf513: an evolutionary phenomenon of recent concern for antibiotic resistance.First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United StatesComparative genomics of an IncA/C multidrug resistance plasmid from Escherichia coli and Klebsiella isolates from intensive care unit patients and the utility of whole-genome sequencing in health care settingsAntibiotic resistance gene abundances associated with waste discharges to the Almendares River near Havana, CubaAntimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarityIdentification of nasal colonization with β-lactamase-producing Enterobacteriaceae in patients, health care workers and students in MadagascarExtraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic ResistanceTwo novel class I integron arrays containing IMP-18 metallo-β-lactamase gene in Pseudomonas aeruginosa clinical isolates from Puerto Rico.Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.Appearance of β-lactam Resistance Genes in Agricultural Soils and Clinical Isolates over the 20th Century.Phenotypic & molecular characterization of AmpC β-lactamases among Escherichia coli, Klebsiella spp. & Enterobacter spp. from five Indian Medical CentersIsolation and Characterization of Antimicrobial-Resistant Nontyphoidal Salmonella enterica Serovars from Imported Food Products.Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals.Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapySurveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community.Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care UnitEvaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.First outbreak of multidrug-resistant Klebsiella pneumoniae producing both SHV-12-type extended-spectrum beta-lactamase and DHA-1-type AmpC beta-lactamase at a Korean hospital.Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamasesMultiresistant Enterobacteriaceae: new threat of an old problem.AmpC beta-lactamases.Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate.Increased waterborne blaNDM-1 resistance gene abundances associated with seasonal human pilgrimages to the upper ganges river.Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment.Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009.KPC screening by updated BD Phoenix and Vitek 2 automated systems.Tackling antimicrobial resistance in lower urinary tract infections: treatment options.Direct comparison of the BD phoenix system with the MicroScan WalkAway system for identification and antimicrobial susceptibility testing of Enterobacteriaceae and nonfermentative gram-negative organisms.In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.Antimicrobial Resistance and Cytotoxicity of Citrobacter spp. in Maanshan Anhui Province, China.Genetic environment of the KPC gene in Acinetobacter baumannii ST2 clone from Puerto Rico and genomic insights into its drug resistance.Emergency (clonal spread) of methicillin-resistant Staphylococcus aureus (MRSA), extended spectrum (ESBL)--and AmpC beta-lactamase-producing Gram-negative bacteria infections at Pediatric Department, Bosnia and Herzegovina.Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases.Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in ChinaDetection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis.
P2860
Q28298371-9A9571F8-57F8-4848-98B8-C95AA3D6851DQ30371239-A68E44E6-094E-451D-BB97-53024CABBF00Q33686219-A04770F4-8AFE-4473-8113-13CEF5FFFB09Q33769534-3333CE5D-4C9E-4168-ABB8-E7CCA393F93BQ33827060-D167C2E4-08FB-4A63-A213-DABF84DB852CQ34045397-D8A6E5C9-FA56-4893-8A04-1C5D30FD8F53Q34058030-28A142F2-6E3E-4563-BB51-5FE70C921E26Q34505354-871F3620-EAAD-482E-8E92-C629902B42FDQ34752032-0A634617-6415-4591-B94E-4CF41002E004Q35213565-25573C62-4DFD-4579-AF37-194EB425E178Q35493039-DAB16731-483A-44BD-ACD9-50AAC7AB1D8BQ35681590-56329691-5728-457B-A90F-952318A91E84Q35867419-F7584337-3818-42DF-8015-FA60330F0CD0Q35912800-564F5CE9-210F-4031-86F1-070644E0A885Q35924144-C09CD576-1F46-4C4D-9587-38FF1AEEE249Q35993279-4E76B5A5-4A64-4407-B842-96BCA19BC90EQ36096711-A1D77065-E3C4-4903-BBD2-16087829AEEDQ36744818-1CA5EFAB-21B8-48EB-9063-FAB2E12AE6A2Q36870786-4EF82587-2482-424C-914B-5EEBBE214A13Q36932909-8991A8FE-3E6E-47AB-B8D0-51FF408731A1Q37021378-58694E88-D061-4504-9167-4694F4264440Q37032817-2D9A1D6F-4772-483D-83D5-B19E544A033AQ37040812-0929715B-6D8F-4818-BA8A-C01F36EDF6D4Q37144824-3EBC6BE6-64CB-4322-9180-CA14DD54ABD9Q37291349-89582106-5E78-4B1B-A3F1-CE47B0EC5FE3Q37366249-69091232-F74A-46A6-8689-9A16C92B081AQ37612954-2E73973F-6DF5-471E-88E4-F9D05E097FF3Q37623473-71DB9A66-6F50-4B98-8C41-8C15F2F8E5DDQ38063968-56188B18-E07F-4EE0-96C4-3702D2338E18Q38126815-13DB0383-080E-454A-92D6-EBAC63E69F2DQ38285014-38EB5F6A-6351-42E8-9C52-BF6A7C784A20Q38833839-1F1C6CD9-9F26-4757-A8A9-301FBD7CC24BQ39762100-50A5FCFD-CC04-431C-805A-F1437DEFE164Q40049619-FAF7A12C-459E-49E5-AE9C-583A5BB83AF5Q40107281-D912AC8A-BDB1-4AFC-9552-37AF46C9B308Q40646501-136B7932-F21A-4049-814A-97046AF58149Q41751870-B1F95EB7-5D43-479E-9174-277B9F04D4E1Q41939169-7FA9554B-32AE-4FDA-82AD-84969DE3C7AEQ41995038-311BB61C-3403-4A29-A4F5-6266042C157DQ42016476-20CEBD59-4AAA-45CE-A8C8-B13ED02AB088
P2860
Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Prevalence of newer beta-lacta ...... nited States from 2001 to 2002
@ast
Prevalence of newer beta-lacta ...... nited States from 2001 to 2002
@en
type
label
Prevalence of newer beta-lacta ...... nited States from 2001 to 2002
@ast
Prevalence of newer beta-lacta ...... nited States from 2001 to 2002
@en
prefLabel
Prevalence of newer beta-lacta ...... nited States from 2001 to 2002
@ast
Prevalence of newer beta-lacta ...... nited States from 2001 to 2002
@en
P2093
P2860
P356
P1476
Prevalence of newer beta-lacta ...... nited States from 2001 to 2002
@en
P2093
Ashfaque Hossain
Ellen S Moland
Jennifer A Black
Kenneth S Thomson
Nancy D Hanson
Wonkeun Song
P2860
P304
P356
10.1128/JCM.00756-06
P407
P577
2006-09-01T00:00:00Z